Exact Sciences Files 8-K: Material Agreement & Equity Sales

Ticker: EXAS · Form: 8-K · Filed: 2024-04-17T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, financial-obligation, equity-sale

Related Tickers: EXAS

TL;DR

EXAS filed an 8-K detailing a material agreement and equity sales - watch for financial implications.

AI Summary

Exact Sciences Corp. entered into a material definitive agreement on April 17, 2024, related to a direct financial obligation. The company also reported on unregistered sales of equity securities and other events. Specific details regarding the financial obligation and equity sales are not fully disclosed in this initial filing.

Why It Matters

This filing indicates potential new financial commitments or debt for Exact Sciences, alongside equity transactions, which could impact its financial structure and shareholder value.

Risk Assessment

Risk Level: medium — The filing mentions material definitive agreements and financial obligations, which inherently carry financial risks, but lacks specific details to assess the magnitude.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement Exact Sciences Corp. entered into?

The filing states that Exact Sciences Corp. entered into a material definitive agreement, but the specific terms and nature of this agreement are not detailed in the provided excerpt.

What type of financial obligation is mentioned in the 8-K filing?

The filing indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant, but specific details are not provided.

Does the 8-K filing provide details on the unregistered sales of equity securities?

The filing lists 'Unregistered Sales of Equity Securities' as an item, but the specifics of these sales, including the amount and price, are not included in the provided text.

What is the principal executive office address for Exact Sciences Corp.?

The principal executive offices of Exact Sciences Corp. are located at 5505 Endeavor Lane, Madison, WI 53719.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on April 17, 2024.

From the Filing

0001124140-24-000020.txt : 20240417 0001124140-24-000020.hdr.sgml : 20240417 20240417160135 ACCESSION NUMBER: 0001124140-24-000020 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 22 CONFORMED PERIOD OF REPORT: 20240417 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240417 DATE AS OF CHANGE: 20240417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 24850938 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 8-K 1 exas-20240417.htm 8-K exas-20240417 0001124140 false 0001124140 2024-04-17 2024-04-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  April 17, 2024   EXACT SCIENCES CORPORATION (Exact Name of Registrant as Specified in Charter)   Delaware   001-35092   02-0478229 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   5505 Endeavor Lane Madison , WI   53719 (Address of Principal Executive Offices)(Zip Code)   Registrant’s telephone number, including area code:   ( 608 ) 284-5700   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐              Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share EXAS The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01.                      Entry

View on Read The Filing